ReviewFrontiers in pediatrics2026
Prodromal behavioral markers and developmental trajectories of autism spectrum disorder in infancy: a narrative review.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social communication deficits and restricted, repetitive behaviors. Despite the rising global prevalence, a significant gap remains between the biological onset of the disorder and the average age of clinical diagnosis (3-5 years). This "diagnostic lag" hinders access to early intervention during the critical window of neuroplasticity. Here, we synthesize recent evidence regarding behavioral markers in the prodromal phase (0-12 months) and the symptom consolidation phase (12-24 months), with a specific focus on the heterogeneity of developmental trajectories. Unlike static disease models, ASD manifests through dynamic "developmental cascades." During the prodromal phase, non-specific signs-such as motor delays, attentional disengagement, and sensory regulatory issues-often precede overt social deficits. By the second year, these early vulnerabilities cascade into core symptoms, including the loss of joint attention, diminished response to name, and the emergence of restricted and repetitive behaviors. We further distinguish between "early-onset" and "regressive" patterns. Ultimately, by integrating empirical evidence with emerging digital phenotyping, we advocate shifting the clinical paradigm from "waiting for diagnosis" to "monitoring developmental trajectories," thereby optimizing early identification strategies to improve long-term outcomes for affected children and their families.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.